VIVUS News

DAX	8.197	-0,4%	Dow	15.112	-1,4%	Euro	1,3257	-0,3%
ESt50	2.684	-0,6%	Nas	3.443	-1,1%	Öl	105,2	-0,5%
TDax	958,4	-0,1%	Nikkei	13.138	-0,8%	Gold	1.348	-0,3%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News	Bilanz/GuV	Dividende/HV	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Schätzungen	Termine	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Profil	Knock-Outs	myHome
Orderbuch	Realtime Stuttgart	Fundamentalanalyse		Insidertrades	Fonds	Senden
Historisch	Realtime Push	myNews		im Forum	Anleihen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Sprache:
Alle
DE
EN

Sortieren:
Datum
meistgelesen

06.06.13	Sarissa's Stake in VIVUS Points to Renewed Interest in the Company (EN, MotleyFool)
04.06.13	First Manhattan Mails Definitive Proxy Statement and Sends Letter to Vivus Stockholders (EN, MotleyFool)
23.05.13	Dissident Holder First Manhattan Adds Three to Vivus Board Slate (FOX Business)
23.05.13	Dissident Holder First Manhattan Adds 3 to Vivus Board Slate (FOX Business)
23.05.13	First Manhattan Adds Alex Denner to Vivus Board Slate (EN, MotleyFool)
13.05.13	Vivus Increases Board to 9 Members (EN, MotleyFool)
08.05.13	First Manhattan Co. Releases Case for Full Board Change at Vivus (EN, MotleyFool)
01.05.13	First Manhattan to Continue With Board Overhaul Push at Vivus (FOX Business)
16.04.13	FDA Loosens Restrictions on Vivus Weight-Loss Pill (EN, TheStreet.com)
10.04.13	Large Vivus Shareholder Seeks More Change (EN, TheStreet.com)
26.03.13	Vivus Piles New Debt On Top Of Excuses (EN, TheStreet.com)
07.03.13	Why VIVUS Is Poised to Keep Plunging (EN, MotleyFool)
01.03.13	Should VIVUS Just Forget This Drug? (EN, MotleyFool)
26.02.13	Mid-Day Market Update: Cracker Barrel Surges On Upbeat Results, VIVUS Drops (EN, Benzinga earnings)
26.02.13	Obesity Pill Ills: Vivus Qsymia Sales Bomb, Arena Sets Belviq Price Ridiculously High (EN, TheStreet.com)
22.02.13	VIVUS Earnings: An Early Look (EN, MotleyFool)
21.02.13	VIVUS Earnings Preview: 3 Things to Watch (EN, MotleyFool)
08.01.13	Will VIVUS Prove Doubters Wrong? (EN, MotleyFool)
07.01.13	Why VIVUS Shares Popped (EN, MotleyFool)
31.12.12	VIVUS Wraps Up Pivotal Year (EN, MotleyFool)
20.12.12	Stocks to Watch: NYSE Euronext, Arris Group, Vivus (EN, The Wall Street Journal Deutschland)
18.12.12	Vivus Strikes Back (EN, MotleyFool)
18.12.12	Hold Your Horses, VIVUS Investors (EN, MotleyFool)
11.12.12	Insider Activity at Vivus Inc (EN, MotleyFool)
11.12.12	Is This the Start of a VIVUS Comeback? (EN, MotleyFool)
04.12.12	Why VIVUS Lost in November (EN, MotleyFool)
27.11.12	Will This Strategy Spark a VIVUS Revival? (EN, MotleyFool)
23.11.12	Good News for Vivus and Arena (EN, MotleyFool)
22.11.12	Everything You Need to Know: Pfizer, Bristol-Myers Squibb, VIVUS, Sarepta, and St. Jude (EN, MotleyFool)
21.11.12	Skechers USA, VIVUS: Biggest Price Gainers (SKX, VVUS) (EN, The Wall Street Journal Deutschland)
21.11.12	Vivus Leads Weight-Loss-Drug Stocks Higher after Aetna Release (EN, The Wall Street Journal Deutschland)
21.11.12	Vivus Leads Weight-Loss-Drug Stocks Higher after Aetna Release (EN, Barrons)
19.11.12	Does VIVUS Have the Right Management Team? (EN, MotleyFool)
16.11.12	Should VIVUS Look for a Buyer? (EN, MotleyFool)
15.11.12	Are Arena and VIVUS Frenemies? (EN, MotleyFool)
14.11.12	Something New for VIVUS Investors to Watch? (EN, MotleyFool)
09.11.12	Does VIVUS Need a Partner? (EN, MotleyFool)
07.11.12	VIVUS Shares Hit Hard after Earnings (EN, Benzinga earnings)
07.11.12	Why Investors Are Voting Against VIVUS (EN, MotleyFool)
06.11.12	Can This Forgotten Drug Save VIVUS Investors? (EN, MotleyFool)

Seite: 12 3 4

19.06.13	Curie-Cancer et Sanofi s’associent dans la recherche contre le cancer de l’ovaire
18.06.13	Wunschanalyse der Woche: Amgen
18.06.13	Sanofi va présenter de nouvelles données cliniques, incluant les résultats de la nouvelle insuline expérimentale U300, aux 73e Séances scientifiques de l’American Diabetes Association
17.06.13	Updates zu Deutsche Telekom, Eon, Hannover Rück und VW
17.06.13	Amgen share buybacks, drugs may fuel more stock gains - Barron's
17.06.13	Amgen share buybacks, drugs may fuel more stock gains - Barron's
12.06.13	ROUNDUP/Aktien New York Schluss: Weiter schwach - Erholungsversuch misslungen
12.06.13	Aktien New York: Weitere Verluste - Milliardenschwere Reifenhochzeit
12.06.13	ROUNDUP/Aktien New York: Kein klarer Trend - Milliardenschwere Reifenhochzeit
12.06.13	Amgen Drug Delays Ovarian Cancer Re-Growth, Survival Benefit Unclear

Finanzen.net

Vivus Aktie [WKN: 893380 / ISIN: US9285511005]

Vivus News

Newssuche

Meistgelesene Vivus News 1M

Vivus Peer Group News